Dow Inc. (DOW) is down sharply in Wednesday trading (April 8, 2026) as investors digest a new wave of negative analyst commentary on the chemicals cycle. The immediate catalyst is a cluster of downgrades and price-target resets that argue recent strength in petrochemical pricing is unlikely to last and that 2026 earnings expectations still look too high.

Bank of America cut Dow to Underperform from Neutral, flagging a setup where near-term pricing power can fade as conditions normalize, leaving the stock exposed if margins roll over later in the cycle. In parallel, BMO also moved to an Underperform stance, warning that without a meaningful improvement in the macro backdrop or significant industry supply reductions, Dow’s 2026 EBITDA could land roughly $1 billion below consensus expectations.

Dow is highly leveraged to commodity chemical spreads and global demand, so analyst changes to mid-cycle assumptions can drive outsized stock moves in a single session. With the market focused on whether petrochemical pricing is peaking into mid-2026 and what that implies for 2027, today’s selloff reflects investors repricing the probability of a faster earnings normalization and less durable margin tailwinds.

Key signposts include any indications of incremental capacity closures (which could tighten supply and support spreads), updates on end-market demand in packaging, construction, and autos, and management commentary around 2026 cash generation priorities. Investors will also watch whether additional firms follow with estimate cuts, which could keep pressure on the stock even if broader equities stabilize.